Developer docs
API playgroundTry for free, no card

Search company profiles

Marken

Full company profile

uuid0006qb5

Namestring
Marken
Legal namestring
Marken LLP
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Marken operates as a clinical trial and advanced therapy logistics provider, functioning as the dedicated life sciences precision logistics division of UPS Healthcare. The company serves pharmaceutical manufacturers, biotechnology firms, CROs, MedTech companies, and nuclear medicine/radiopharma clients across 220+ countries and territories, orchestrating approximately 6.6 million shipments annually through a harmonized network of 4,000 experts. Its service portfolio spans Health Chain Orchestration (GMP-compliant drug storage and distribution), Advanced Therapy Logistics (cell and gene therapy, cryogenic transport at -196°C LN2, radiopharmaceuticals, vein-to-vein delivery), Connected Medical Device Logistics, Patient Driven Services (DTP/DTC, home healthcare, decentralized clinical trials across 90+ countries), Laboratory Advantage (kit building and specimen transport), Complex Secure Logistics (AOG, next-flight-out, high-value shipments), and Packaging as a Service.

The technology architecture is anchored by the AIR TECH framework, introduced in 2024, which unifies eight proprietary digital platforms: Maestro (shipment booking and compliant documentation), Solo (depot inventory visibility), Apollo (home-health visit scheduling for clinical trials), Helios (biological sample kit design and tracking, launched 2024), MxWeb (urgent shipment self-service), NetShip (courier logistics execution), Polar Track (live temperature/location tracking), and Polar Care (prescription management and appointment scheduling). AI is applied to predictive analytics, route optimization, anomaly detection in temperature excursions, and process automation in kit production, all monitored through a 24/7 global control tower.

Marken generates revenue through managed-services contracts negotiated on a quote basis with enterprise clients, supplemented by usage-based fuel surcharges (currently 57.50% as of June 2026, tied to US west coast mid-grade reformulated gasoline prices). Distribution is direct via enterprise field sales with dedicated project teams; the company is a wholly-owned subsidiary of UPS Healthcare, legally domiciled as Marken LLP in the United Kingdom (London), with recent brand consolidations integrating the formerly standalone MNX (radiopharmaceuticals and aviation) and Polar Speed (UK pharmacy and homecare) businesses under the unified Marken, UPS Healthcare Precision Logistics brand in 2025.

Short descriptiontext

Marken provides global clinical trial and advanced therapy logistics for pharmaceutical, biotech, CRO, and MedTech clients across 220+ countries, handling 6.6 million shipments annually through UPS Healthcare's precision logistics network with proprietary cold-chain and cryogenic capabilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial logistics, pharmaceutical cold chain, cell and gene therapy logistics, advanced therapy transport, patient-centric supply chain
Industry5 codes
1Clinical Trials & Investigational Product (IP) Cold Delivery
CodeTLAAAJAEPrimaryYes
2Pharmaceutical Cold-Chain Delivery (2–8°C / CRT)
CodeTLAAAJACPrimaryNo
3Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)
CodeTLAIAGAIPrimaryNo
4Pharmaceuticals & Life Sciences Forwarding (GxP/GDP)
CodeTLACAJABPrimaryNo
5Blood, Plasma & Human Tissue Cold Delivery
CodeTLAAAJAGPrimaryNo
NAICS code4 codes
  • Couriers and Express Delivery Services492110
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Local Messengers and Local Delivery49221
  • Packaging and Labeling Services56191
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Services-Health Services8000
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Clinical Trial Logistics Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Clinical Trial Logistics Services
TypeManaged Services
Description

End-to-end logistics services for clinical trials including specimen transport, kit building, storage, and distribution across global investigator sites.

marken.com
2Advanced Therapy Logistics
TypeManaged Services
Description

Specialized logistics for cell and gene therapies, radiopharmaceuticals, and complex biologics requiring cryogenic and ultra-cold temperature control.

marken.com
3Patient-Centric/Direct-to-Patient Services
TypeManaged Services
Description

Direct-to/from-patient logistics, home healthcare visits, and nursing network services supporting decentralized clinical trials.

marken.com
4Packaging as a Service
TypeManaged Services
Description

Validated temperature-controlled packaging solutions, dry ice capabilities, and closed-loop logistics for pharmaceutical cold chain.

marken.com
5Complex Secure Logistics
TypeManaged Services
Description

Time-critical logistics for high-value shipments, aircraft on ground (AOG) support, next flight out services, and specialized airfreight.

marken.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Fuel Surcharge - Variable rate applied to shipments
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Current fuel surcharge rate is 57.50% as of June 23, 2026, based on US west coast mid-grade reformulated gasoline prices.

marken.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 11 records shown
1Marken Apollo™
Description

A compliant digital system for scheduling and managing home-health visits tied to clinical trials.

marken.com
+10 more records
Core offering1 text field

Marken provides patient-centric supply chain solutions for the life sciences industry, specializing in clinical trial and advanced therapy logistics. The company orchestrates end-to-end pharmaceutical logistics including GMP-compliant storage, temperature-controlled transport across all ranges (ambient to cryogenic LN2 -196°C), direct-to-patient delivery, biological sample kit production, and complex secure time-critical shipments. Operating across 220+ countries through a network of 4,000 experts handling 6.6 million shipments annually, Marken serves pharmaceutical companies, biotech firms, CROs, and MedTech manufacturers as the clinical and advanced therapy logistics division of UPS Healthcare.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 99.5% on-time performance rate for Laboratory Advantage services
+3 more records
Product overview1 text field

Marken operates as a unified platform-plus-modules architecture under the 'Marken, UPS Healthcare Precision Logistics' brand. The portfolio consists of multiple proprietary digital platforms (Maestro, Solo, Apollo, Helios, MxWeb, NetShip, Polar Care, Polar Track) unified by the AIR TECH framework, which powers end-to-end visibility across all services. These platforms are complemented by seven core service lines: Health Chain Orchestration (drug storage/distribution), Advanced Therapy Logistics (cell/gene therapy, nuclear medicine), Connected Medical Device Logistics, Patient Driven Services (DTP/DTC, home healthcare), Laboratory Advantage (kit building, specimen logistics), Complex Secure Logistics (AOG, NFO, high-value), and Packaging as a Service. MNX (radiopharmaceuticals, aviation logistics) and Polar Speed (UK pharmacy/homecare) are integrated sub-brands extending specific capabilities. The company orchestrates 6.6M shipments annually across 220+ countries and territories through a network of 4,000 experts.

Product and service8 records
1Health Chain Orchestration
CategoryCore Logistics Service
2Advanced Therapy Logistics
CategoryCore Logistics Service
3Connected Medical Device Logistics & Management
CategoryCore Logistics Service
4Patient Driven Services
CategoryCore Logistics Service
5Laboratory Advantage
CategoryCore Logistics Service
6Complex Secure Logistics
CategoryCore Logistics Service
7Packaging as a Service
CategoryCore Logistics Service
8Polar Speed Services
CategorySub-brand Service
Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Marken is the clinical and advanced therapy logistics division of UPS Healthcare Precision Logistics. The partnership provides Marken access to UPS Healthcare's global logistics infrastructure including aircraft fleet, global network, and operational scale.

Strategic tierPreferredTypeStrategic or Co-development Partner
Description

Specialty airline partner providing priority handling and rapid delivery services for time-critical medical shipments.

3United Lifeguard XL
Strategic tierPreferredTypeStrategic or Co-development Partner
Description

Specialty airline partner for priority handling and rapid delivery of critical healthcare shipments.

marken.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Leading MedTech company partnered with Marken for connected medical device logistics, installation, and patient support services.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Medical device company partnered for logistics and support of Zoll medical devices including defibrillation equipment.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Major MedTech company partnered for medical device logistics and distribution services.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Healthcare company partnered for infusion therapy and medical device logistics services.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

MedTech and healthcare company partnered for medical device and renal care logistics.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

World Courier is a Cencora subsidiary specializing in global clinical trial logistics, pharmaceutical cold chain, and direct-to-patient services. It is Marken's most direct competitor in specialty pharma logistics with similar temperature-controlled capabilities and global depot network.

TypeBroad incumbent
Description

DHL Supply Chain operates one of the world's largest contract logistics platforms with dedicated life sciences and healthcare verticals including clinical trial logistics, cold chain distribution, and pharma warehousing. It competes broadly with Marken across global pharma logistics while serving many of the same enterprise customers.

TypeBroad incumbent
Description

Kuehne+Nagel is a global freight forwarder with a dedicated life sciences and healthcare vertical providing clinical trial logistics, cold chain solutions, and pharma distribution. It is a major broad incumbent competing with Marken across international pharma forwarding and temperature-controlled transport.

TypeEmerging player
Description

BioStorage Technologies specializes in biological sample storage, management, and global distribution for clinical trials and research. It overlaps with Marken's Laboratory Advantage service line and biospecimen logistics capabilities, serving similar biotech and CRO customers.

TypeEmerging player
Description

Catalent is a global CDMO with growing clinical supply chain services including clinical trial material packaging, labeling, and distribution. While primarily a manufacturer, its clinical supply services overlap with Marken's kit building, GMP depot, and investigational product distribution capabilities.

TypeBroad incumbent
Description

Cencora is a Fortune 10 pharmaceutical distribution and services company that owns World Courier and provides integrated specialty logistics, third-party logistics, and clinical trial support services. It competes with Marken across multiple service lines through World Courier and broader pharma distribution.

TypeBroad incumbent
Description

FedEx Custom Critical provides time-sensitive, temperature-controlled shipping for healthcare and life sciences customers including pharma and biotech. It overlaps with Marken's Complex Secure Logistics service line and offers comparable expedited medical courier capabilities.

TypeBroad incumbent
Description

Cardinal Health is a major pharmaceutical distributor with specialty logistics capabilities serving pharma and biotech customers. While broader in scope, its specialty distribution services overlap with Marken's commercial pharma distribution and cold chain capabilities for advanced therapies.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with integrated clinical trial supply chain services including biological sample management, central laboratory logistics, and direct-to-patient services. It overlaps with Marken's CRO customer-facing logistics offerings and competes in decentralized trial enablement.

TypeBroad incumbent
Description

DB Schenker operates a dedicated life sciences logistics vertical providing temperature-controlled airfreight, road transport, and clinical trial supply chain services. It is a broad incumbent offering comparable pharmaceutical logistics capabilities across major global trade lanes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Marken

Clinical Trial Logistics Servicesmarken.com

Marken provides global clinical trial and advanced therapy logistics for pharmaceutical, biotech, CRO, and MedTech clients across 220+ countries, handling 6.6 million shipments annually through UPS Healthcare's precision logistics network with proprietary cold-chain and cryogenic capabilities.

What Marken does

Marken operates as a clinical trial and advanced therapy logistics provider, functioning as the dedicated life sciences precision logistics division of UPS Healthcare. The company serves pharmaceutical manufacturers, biotechnology firms, CROs, MedTech companies, and nuclear medicine/radiopharma clients across 220+ countries and territories, orchestrating approximately 6.6 million shipments annually through a harmonized network of 4,000 experts. Its service portfolio spans Health Chain Orchestration (GMP-compliant drug storage and distribution), Advanced Therapy Logistics (cell and gene therapy, cryogenic transport at -196°C LN2, radiopharmaceuticals, vein-to-vein delivery), Connected Medical Device Logistics, Patient Driven Services (DTP/DTC, home healthcare, decentralized clinical trials across 90+ countries), Laboratory Advantage (kit building and specimen transport), Complex Secure Logistics (AOG, next-flight-out, high-value shipments), and Packaging as a Service.

The technology architecture is anchored by the AIR TECH framework, introduced in 2024, which unifies eight proprietary digital platforms: Maestro (shipment booking and compliant documentation), Solo (depot inventory visibility), Apollo (home-health visit scheduling for clinical trials), Helios (biological sample kit design and tracking, launched 2024), MxWeb (urgent shipment self-service), NetShip (courier logistics execution), Polar Track (live temperature/location tracking), and Polar Care (prescription management and appointment scheduling). AI is applied to predictive analytics, route optimization, anomaly detection in temperature excursions, and process automation in kit production, all monitored through a 24/7 global control tower.

Marken generates revenue through managed-services contracts negotiated on a quote basis with enterprise clients, supplemented by usage-based fuel surcharges (currently 57.50% as of June 2026, tied to US west coast mid-grade reformulated gasoline prices). Distribution is direct via enterprise field sales with dedicated project teams; the company is a wholly-owned subsidiary of UPS Healthcare, legally domiciled as Marken LLP in the United Kingdom (London), with recent brand consolidations integrating the formerly standalone MNX (radiopharmaceuticals and aviation) and Polar Speed (UK pharmacy and homecare) businesses under the unified Marken, UPS Healthcare Precision Logistics brand in 2025.

Marken firmographics

Firmographics
Name
Marken
Legal name
Marken LLP
Website
https://www.marken.com/
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Marken provides global clinical trial and advanced therapy logistics for pharmaceutical, biotech, CRO, and MedTech clients across 220+ countries, handling 6.6 million shipments annually through UPS Healthcare's precision logistics network with proprietary cold-chain and cryogenic capabilities.
Ownership category
akta.pro rank

Marken industry classification

Industry
Product category
Clinical Trial Logistics Services
NAICS
Couriers and Express Delivery Services (492110), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Local Messengers and Local Delivery (49221), Packaging and Labeling Services (56191)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Health Services (8000), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Clinical Trials & Investigational Product (IP) Cold Delivery (TLAAAJAE)
akta.pro secondary industries
Pharmaceutical Cold-Chain Delivery (2–8°C / CRT) (TLAAAJAC), Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI), Pharmaceuticals & Life Sciences Forwarding (GxP/GDP) (TLACAJAB), Blood, Plasma & Human Tissue Cold Delivery (TLAAAJAG)

Keywords

  • Clinical trial logistics
  • Pharmaceutical cold chain
  • Cell and gene therapy logistics
  • Advanced therapy transport
  • Patient-centric supply chain

Where Marken is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Marken business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Trial Logistics Services: End-to-end logistics services for clinical trials including specimen transport, kit building, storage, and distribution across global investigator sites.
  2. Advanced Therapy Logistics: Specialized logistics for cell and gene therapies, radiopharmaceuticals, and complex biologics requiring cryogenic and ultra-cold temperature control.
  3. Patient-Centric/Direct-to-Patient Services: Direct-to/from-patient logistics, home healthcare visits, and nursing network services supporting decentralized clinical trials.
  4. Packaging as a Service: Validated temperature-controlled packaging solutions, dry ice capabilities, and closed-loop logistics for pharmaceutical cold chain.
  5. Complex Secure Logistics: Time-critical logistics for high-value shipments, aircraft on ground (AOG) support, next flight out services, and specialized airfreight.

Pricing tiers

ModelBillingPrice
Usage-basedPay-as-you-goFuel Surcharge - Variable rate applied to shipments

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Marken product offering

Product offering

Core offering

Marken provides patient-centric supply chain solutions for the life sciences industry, specializing in clinical trial and advanced therapy logistics. The company orchestrates end-to-end pharmaceutical logistics including GMP-compliant storage, temperature-controlled transport across all ranges (ambient to cryogenic LN2 -196°C), direct-to-patient delivery, biological sample kit production, and complex secure time-critical shipments. Operating across 220+ countries through a network of 4,000 experts handling 6.6 million shipments annually, Marken serves pharmaceutical companies, biotech firms, CROs, and MedTech manufacturers as the clinical and advanced therapy logistics division of UPS Healthcare.

Product overview

Marken operates as a unified platform-plus-modules architecture under the 'Marken, UPS Healthcare Precision Logistics' brand. The portfolio consists of multiple proprietary digital platforms (Maestro, Solo, Apollo, Helios, MxWeb, NetShip, Polar Care, Polar Track) unified by the AIR TECH framework, which powers end-to-end visibility across all services. These platforms are complemented by seven core service lines: Health Chain Orchestration (drug storage/distribution), Advanced Therapy Logistics (cell/gene therapy, nuclear medicine), Connected Medical Device Logistics, Patient Driven Services (DTP/DTC, home healthcare), Laboratory Advantage (kit building, specimen logistics), Complex Secure Logistics (AOG, NFO, high-value), and Packaging as a Service. MNX (radiopharmaceuticals, aviation logistics) and Polar Speed (UK pharmacy/homecare) are integrated sub-brands extending specific capabilities. The company orchestrates 6.6M shipments annually across 220+ countries and territories through a network of 4,000 experts.

Differentiator

Problem solved

Functional benefit

Brands

  • Marken Apollo™: A compliant digital system for scheduling and managing home-health visits tied to clinical trials.
  • Marken FastTrack™
  • Marken Maestro™
  • Marken Solo™
  • MxWeb
  • NetShip
  • Polar Track
  • Polar Care
  • Helios™
  • MNX
  • Polar Speed

Products and services

  • Health Chain Orchestration
  • Advanced Therapy Logistics
  • Connected Medical Device Logistics & Management
  • Patient Driven Services
  • Laboratory Advantage
  • Complex Secure Logistics
  • Packaging as a Service
  • Polar Speed Services

Quantifiable outcome

  • 99.5% on-time performance rate for Laboratory Advantage services
  • +3 more outcomes

Companies that use Marken

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Marken technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature12 records

Marken partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, preferred and major.

  • UPS HealthcarecoreStrategic or Co-development PartnerMarken is the clinical and advanced therapy logistics division of UPS Healthcare Precision Logistics. The partnership provides Marken access to UPS Healthcare's global logistics infrastructure including aircraft fleet, global network, and operational scale.
  • Delta DASH CriticalpreferredStrategic or Co-development PartnerSpecialty airline partner providing priority handling and rapid delivery services for time-critical medical shipments.
  • United Lifeguard XLpreferredStrategic or Co-development PartnerSpecialty airline partner for priority handling and rapid delivery of critical healthcare shipments.
  • PhilipsmajorStrategic or Co-development PartnerLeading MedTech company partnered with Marken for connected medical device logistics, installation, and patient support services.
  • ZollmajorStrategic or Co-development PartnerMedical device company partnered for logistics and support of Zoll medical devices including defibrillation equipment.
  • BD (Becton Dickinson)majorStrategic or Co-development PartnerMajor MedTech company partnered for medical device logistics and distribution services.
  • FreseniusmajorStrategic or Co-development PartnerHealthcare company partnered for infusion therapy and medical device logistics services.
  • BaxtermajorStrategic or Co-development PartnerMedTech and healthcare company partnered for medical device and renal care logistics.

Scale indicators16 records

Recent moves6 records

Expansion highlights5 records

Marken competitors and assessment

Company assessment

Direct peers

  • World Courier: World Courier is a Cencora subsidiary specializing in global clinical trial logistics, pharmaceutical cold chain, and direct-to-patient services. It is Marken's most direct competitor in specialty pharma logistics with similar temperature-controlled capabilities and global depot network.

Broad incumbents

  • DHL Supply Chain (Life Sciences): DHL Supply Chain operates one of the world's largest contract logistics platforms with dedicated life sciences and healthcare verticals including clinical trial logistics, cold chain distribution, and pharma warehousing. It competes broadly with Marken across global pharma logistics while serving many of the same enterprise customers.
  • Kuehne+Nagel (Life Sciences & Healthcare): Kuehne+Nagel is a global freight forwarder with a dedicated life sciences and healthcare vertical providing clinical trial logistics, cold chain solutions, and pharma distribution. It is a major broad incumbent competing with Marken across international pharma forwarding and temperature-controlled transport.
  • Cencora (formerly AmerisourceBergen): Cencora is a Fortune 10 pharmaceutical distribution and services company that owns World Courier and provides integrated specialty logistics, third-party logistics, and clinical trial support services. It competes with Marken across multiple service lines through World Courier and broader pharma distribution.
  • FedEx Custom Critical: FedEx Custom Critical provides time-sensitive, temperature-controlled shipping for healthcare and life sciences customers including pharma and biotech. It overlaps with Marken's Complex Secure Logistics service line and offers comparable expedited medical courier capabilities.
  • Cardinal Health (Specialty Logistics): Cardinal Health is a major pharmaceutical distributor with specialty logistics capabilities serving pharma and biotech customers. While broader in scope, its specialty distribution services overlap with Marken's commercial pharma distribution and cold chain capabilities for advanced therapies.
  • IQVIA (Clinical Trial Logistics): IQVIA is the world's largest CRO with integrated clinical trial supply chain services including biological sample management, central laboratory logistics, and direct-to-patient services. It overlaps with Marken's CRO customer-facing logistics offerings and competes in decentralized trial enablement.
  • DB Schenker Life Sciences: DB Schenker operates a dedicated life sciences logistics vertical providing temperature-controlled airfreight, road transport, and clinical trial supply chain services. It is a broad incumbent offering comparable pharmaceutical logistics capabilities across major global trade lanes.

Emerging players

  • BioStorage Technologies: BioStorage Technologies specializes in biological sample storage, management, and global distribution for clinical trials and research. It overlaps with Marken's Laboratory Advantage service line and biospecimen logistics capabilities, serving similar biotech and CRO customers.
  • Catalent: Catalent is a global CDMO with growing clinical supply chain services including clinical trial material packaging, labeling, and distribution. While primarily a manufacturer, its clinical supply services overlap with Marken's kit building, GMP depot, and investigational product distribution capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks2 records

Key highlights7 records

Customer concentration

Marken social profiles

Digital presence

Marken compliance and trust

Trust signal

Compliance8 records

Marken financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Marken leadership team

Management profile

Number of profiles

Profiles10 records

Marken subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Marken funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Marken M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Marken

What does Marken do?

Marken provides patient-centric supply chain solutions for the life sciences industry, specializing in clinical trial and advanced therapy logistics. The company orchestrates end-to-end pharmaceutical logistics including GMP-compliant storage, temperature-controlled transport across all ranges (ambient to cryogenic LN2 -196°C), direct-to-patient delivery, biological sample kit production, and complex secure time-critical shipments. Operating across 220+ countries through a network of 4,000 experts handling 6.6 million shipments annually, Marken serves pharmaceutical companies, biotech firms, CROs, and MedTech manufacturers as the clinical and advanced therapy logistics division of UPS Healthcare.

Is Marken a public or private company?

Marken is a private company. It is classified as corporate owned and is currently operating.

When was Marken founded?

Marken was founded in 1980. It employs 501 to 1,000 people.

Where is Marken based?

Marken is headquartered in Durham, United States, in the North America region.

How does Marken make money?

Five revenue lines are on record. Clinical Trial Logistics Services are the primary driver. The others are advanced Therapy Logistics, patient-Centric/Direct-to-Patient Services, packaging as a Service and complex Secure Logistics.

Who are Marken's main competitors?

World Courier is listed as a direct peer. Broad incumbents are DHL Supply Chain (Life Sciences), Kuehne+Nagel (Life Sciences & Healthcare), Cencora (formerly AmerisourceBergen), FedEx Custom Critical, Cardinal Health (Specialty Logistics), IQVIA (Clinical Trial Logistics) and DB Schenker Life Sciences. Emerging players are BioStorage Technologies and Catalent.

Does Marken have an API?

No public API is recorded for Marken.

What industry is Marken in?

Marken's product category is Clinical Trial Logistics Services. Its primary akta.pro industry code is TLAAAJAE, Clinical Trials & Investigational Product (IP) Cold Delivery, with a secondary code of TLAAAJAC, Pharmaceutical Cold-Chain Delivery (2–8°C / CRT). Its NAICS code is 492110 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AIR CARGO WEEKTurning Emissions Data into a Competitive AdvantageMarken established shipment-level emissions transparency using recognized standards, creating an auditable baseline across its transport network. It works with airlines and road carriers to adopt Sustainable Aviation Fuel and Hydrotreated Vegetable Oil, with reductions tied to physical fuel investments and verified claims. Verified data and external assurance help Marken support customers' sustainability targets and differentiate competitively.Tech TimesMalaysia’s Data Centre Demand Peaks in 2030; Nuclear Grid Relief Arrives Too LateMalaysia's data centre electricity demand is projected to surge from 8.5 terawatt-hours in 2024 to 68 terawatt-hours by 2030, potentially consuming 30% of the nation's entire power supply, while nuclear small modular reactors — the proposed solution — cannot arrive before the 2028–2030 peak crisis window. A Deloitte analysis projects Asia Pacific data centre electricity demand could exceed 1,000 terawatt-hours by mid-2030s, with Southeast Asia facing a compounding energy gap as 70% of the ASEAN grid still runs on coal and gas. Meanwhile, Marken (UPS Healthcare Precision Logistics) announced on August 4, 2026, a fully integrated end-to-end clinical and commercial logistics solution across APAC, adding over 300,000 square feet of GMP- and GDP-compliant storage including three facilities in Singapore, as pharmaceutical companies increasingly commit structurally to the region.PharmaCommerceUPS Healthcare Logistics acquires Marken, consolidating clinical trial logistics providersUPS Healthcare Logistics has acquired Marken, a leading clinical trial logistics provider, for an unspecified price, consolidating the clinical trial materials management market under a major drug distributor. Marken manages approximately 45,000 investigator sites, serves hundreds of drug-development companies, and operates around 40 central labs worldwide. The acquisition builds on UPS's earlier expansion of clinical trial services and positions the company to capture growth in cellular and gene-based therapies that require specialized cold-chain and chain-of-custody services.MarkenGlobal Pharma Logistics Summit - MarkenMarken has announced the eighth edition of its annual Global Pharma Logistics Summit (GPLS 2025), a one-day conference and networking event focused on the evolving global pharma supply chain. The event frames its agenda around geopolitical shifts and the rise of protectionist trade policies that threaten long-standing low-cost production models. The conference will explore India's potential to transition from a low-cost volume supplier to a proactive leader in global pharma logistics, emphasizing resilience, quality, compliance, and value creation.FiercePharmaAccelerating clinical trials with precision logisticsMarken, a UPS Healthcare Precision Logistics company, is highlighting its Laboratory Advantage service line designed to support clinical trials through speed, accuracy, and visibility. The interview with Manishaa O'Brien, director of commercial operations, emphasizes Marken's 99.5% on-time performance rate, real-time tracking capabilities, and use of digital technologies including AI, RFID, and IoT. The company reports that automation, advanced data capture, and sustainable practices are increasingly shaping the future of specimen logistics for clinical supply chains.ContractpharmaKeeping Clinical Trials on TrackIn this Q&A interview, Jose Ianez, Senior Director of Logistics Operations LATAM at Marken, discusses how the company's Laboratory Advantage service helps sponsors manage clinical trial supply chains, emphasizing speed, sample integrity, and regulatory compliance as core priorities. Marken addresses challenges including regulatory changes mid-shipment, infrastructure limitations, and customs delays—such as a prolonged customs strike in Brazil where the company maintained operations through local authority relationships. The interview highlights Marken's technology offerings including 24/7 control towers with real-time tracking, temperature sensors, and sustainable packaging solutions like InfiniDI and InDigo, while positioning the company as an integrated partner for sponsors managing increasingly complex decentralized and hybrid clinical trials.Clinical Trials ArenaTechnology a key tool in successful clinical supply managementAt Arena International Events Group's CTS Europe conference held in Barcelona on 24-25 February 2026, industry experts discussed how predictive analytics, real-time monitoring, and agentic AI are transforming clinical trial supply chain management. Sensitech presented its cloud-based temperature monitoring platform with automated data upload protocols that address the pain point of low logger upload rates at clinical trial sites, while Marken's Gunter Van Hoof argued the industry must shift from reactive to proactive supply chain oversight using agentic AI to enable predictive management with real-time tracking across all data points.The HinduWest Asia conflict disrupts pharma air routes; risks cancer drugs supplyThe West Asia conflict, sparked by U.S. and Israeli attacks on Iran and subsequent Iranian strikes, has disrupted pharmaceutical supply routes to the Gulf region, closing major air cargo hubs including Dubai, Abu Dhabi, and Doha. Industry executives report that cold-chain corridors for temperature-sensitive medicines, particularly cancer drugs, are being severely impacted, with some companies warning hospitals could face shortages within four to six weeks if disruptions continue. Pharmaceutical and logistics companies including Pharma.Aero, Kuehne+Nagel, and Marken are actively rerouting shipments through alternative hubs in Saudi Arabia, Oman, and Turkey, though longer transit times and fuel costs are driving up transportation expenses.The Times of IndiaMiddle East Conflict Disrupts Cancer Drug Supply Chains, ETInfraThe Middle East conflict sparked by US and Israeli attacks on Iran has disrupted critical medicine supply routes to the Gulf region, closing major air transit hubs including Dubai, Abu Dhabi, and Doha that handle temperature-sensitive pharmaceutical cargo. Western drugmakers and logistics firms including Emirates, Etihad, DHL, Kuehne+Nagel, and Marken are actively rerouting shipments through alternative corridors in Jeddah, Riyadh, and Oman to maintain supply chains. Healthcare executives warn that cold-chain disruptions could cause some Gulf customers to run low on short shelf-life cancer drugs within four to six weeks if the conflict persists.openPR.comPharmaceutical Third-party Logistics Market is Booming Worldwide |Marken, Expeditors, Cardinal HealthThe report examines the global Pharmaceutical Third-party Logistics Market, highlighting its current dynamics, technological adoption, and future growth projections through 2033. Key players include DHL Supply Chain, UPS Healthcare, and Cardinal Health, among others.